German CLL Studygroup

International Workshop on CLL 2025

An expert multidisciplinary panel review the latest developments in CLL and the evolving role of BTK inhibitors via an interactive agenda including presentations, ‘Ask the Experts’ sessions and workshops.

Duration: 01:05:19

Duration: 01:00:28

Duration: 01:02:01

Duration: 01:01:03

Clemens Wendtner, Talha Munir, and Alessandra Tedeschi look back on the year so far in CLL, reviewing developments from clinical trials as well as real-world and comparative studies before considering how data drive individual treatment decisions.

Alessandra Tedeschi, Lucrecia Yáñez and Thorsten Zenz use interactive patient case studies to illustrate the role of prior treatment experience, genetic/cytogenetic changes, comorbidities, and patient preference in guiding treatment choices in R/R CLL.

Paolo Ghia, Davide Rossi and Anna Schuh discuss diagnosis and prognosis in CLL, including a case study on the differential diagnosis of accelerated CLL and Richter’s syndrome and a debate on the clinical relevance of IGHV and TP53 as biomarkers.